52 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
with respect to dividends, liquidation rights and, possibly, voting rights. The ability of our board of directors to issue preferred stock also could have … , conversion or exchange rights, voting rights (including the number of votes per share), redemption rights and terms, liquidation preferences, sinking fund
424B5
MBRX
Moleculin Biotech Inc
22 Dec 23
Prospectus supplement for primary offering
5:00pm
, including any voting rights, until they exercise their pre-funded warrants.
S-10
Plan of Distribution
We have engaged Maxim Group LLC to act as our
8-K
EX-4.1
MBRX
Moleculin Biotech Inc
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
8-K
EX-3.1
1eat qnoadv5bu4
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-4.2
ftzl 78d00fcy0g
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-3.1
h2abl9 ihwu
21 Aug 23
Amendments to Articles of Incorporation or Bylaws
5:17pm
8-K
EX-10.1
u6jswlkr 0c
27 Dec 21
Entry into a Material Definitive Agreement
8:06am
8-K
EX-3.1
4ei5 lr75k
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-1.1
eyi7b43bonqfltpn
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
424B5
iay74trx2 0j
2 Feb 21
Prospectus supplement for primary offering
4:29pm